Biotechnology Development

 

Micropoint biotechnology R&D leverages strong collaboration with groups of researchers and scientists around the world to develop novel biomarkers and antibodies that are customized to meet the rapid diagnostic needs. These co-development programs encompass sets/libraries of bio-marker screening, cell line engineering, protein expression, and bio-processing.

 

Micropoint works with its partners to develop novel bio-markers and antibodies with high affinity and high specificity in each of the following stages:

 

• Hybridoma development

• Polyclonal antibody

• Antibody purification

• Antibody Fragmentation and isotyping

• Conjugation and labeling

• Immune response testing

• Novel assay development

• Bio-signal amplifications